Most Recent
A class action against cruise operator Carnival PLC over the 2020 COVID-19 outbreak aboard the Ruby Princess will ask the High Court to hear a challenge to a decision that found a class action waiver for foreign passengers was not unfair.
As he approaches his retirement, High Court Justice Patrick Keane was farewelled by the court’s Chief Justice this week, honoured for his "powerful intellect and industry".
ClubsNSW has lost a bid to keep its contempt of court case against whistleblower Troy Stolz and YouTuber Jordan Shanks secret, with a judge finding “the interests of open justice are paramount”.
Commonwealth Director of Public Prosecutions Sarah McNaughton SC has been appointed as a judge on the NSW Supreme Court, bolstering the court's criminal expertise.
The Full Federal Court has thrown out a decision that found foreign passengers could join a class action against cruise operator Carnival PLC over the 2020 COVID-19 outbreak aboard the Ruby Princess, finding a class action waiver was not unfair.
Chief Justice Susan Kiefel has decried the low number of women barristers appearing in the High Court, questioning whether there is a “price” to pay for state and federal policies focused on appointing more female judges.
An appeals court has dismissed a challenge brought by a Snap Fitness franchisee to a ruling that found insurer Lloyd’s could rely on a conformity clause in its policy to deny business interruption coverage to the NSW gym for losses related to COVID-19.
The state of Victoria can't duck class action claims that failures in its hotel quarantine program caused businesses to suffer losses when stage three and four restrictions were put in place during the state's second wave of COVID-19 cases in 2020.
Fulfilling a pre-election promise, the Albanese government has announced a royal commission into the controversial Robodebt scheme initiated by the previous federal government, which raised more than $1.7 billion in illegitimate debts from Centrelink recipients.
Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.